Profile data is unavailable for this security.
About the company
Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
- Revenue in NOK (TTM)16.10m
- Net income in NOK-51.80m
- Incorporated2006
- Employees32.00
- LocationLifecare ASAYtrebygdsvegen 215BERGEN 5258NorwayNOR
- Websitehttps://lifecare.no/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kancera AB | 0.00 | -54.67m | 240.95m | 5.00 | -- | 2.82 | -- | -- | -0.5955 | -0.5955 | 0.00 | 0.6849 | 0.00 | -- | -- | 0.00 | -56.73 | -54.82 | -66.40 | -66.21 | -- | 96.28 | -- | -7,249.06 | -- | -- | 0.00 | -- | -- | -- | -23.64 | -- | -- | -- |
| Xbrane Biopharma AB | 197.68m | -351.18m | 245.80m | 71.00 | -- | 0.7835 | -- | 1.24 | -1.01 | -1.26 | 0.3403 | 0.1991 | 0.209 | 0.7028 | 24.13 | 2,063,301.00 | -37.14 | -40.98 | -66.96 | -67.24 | 43.32 | -- | -177.65 | -364.40 | 1.07 | -20.51 | 0.357 | -- | 314.33 | 63.42 | -91.10 | -- | 60.02 | -- |
| Ascelia Pharma AB | 0.00 | -63.65m | 247.45m | 13.00 | -- | 2.62 | -- | -- | -1.26 | -1.26 | 0.00 | 0.9554 | 0.00 | -- | -- | 0.00 | -52.75 | -- | -65.92 | -- | -- | -- | -- | -- | -- | -40.42 | 0.4167 | -- | -- | -- | 16.72 | -- | -- | -- |
| Intervacc AB | 10.07m | -105.75m | 284.00m | 15.00 | -- | 1.36 | -- | 28.19 | -1.36 | -1.36 | 0.1291 | 2.68 | 0.0355 | 3.19 | 1.62 | 651,933.30 | -37.23 | -17.62 | -40.38 | -18.77 | -551.10 | -243.59 | -1,049.76 | -626.90 | 2.90 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
| Xintela AB | 392.50k | -42.06m | 295.89m | -- | -- | -- | -- | 753.87 | -0.0817 | -0.0817 | 0.0008 | -0.0319 | 0.0306 | -- | 0.0493 | -- | -327.65 | -181.06 | -- | -391.61 | 100.00 | -- | -10,717.06 | -235,894.00 | -- | -203.91 | -- | -- | -- | -45.54 | 18.32 | -- | -61.47 | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -53.94m | 299.79m | 4.00 | -- | 8.08 | -- | -- | -0.1873 | -0.1873 | 0.00 | 0.0676 | 0.00 | -- | -- | 0.00 | -162.59 | -125.42 | -220.41 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Abliva AB | 141.13k | -105.21m | 304.54m | 6.00 | -- | 2.87 | -- | 2,157.81 | -0.0928 | -0.0928 | 0.0001 | 0.0638 | 0.0013 | -- | 0.0062 | -- | -93.81 | -74.59 | -103.87 | -86.98 | -35,826.28 | -- | -74,542.34 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| Lifecare ASA | 16.10m | -51.80m | 331.98m | 32.00 | -- | 2.69 | -- | 20.63 | -0.3152 | -0.3152 | 0.0999 | 0.632 | 0.1564 | -- | -- | 502,995.00 | -50.29 | -40.00 | -56.16 | -45.26 | -- | -- | -321.48 | -175.53 | -- | -- | 0.0918 | -- | -40.88 | 30.29 | -101.74 | -- | -- | -- |
| Curasight A/S | -44.60m | -49.82m | 347.71m | 4.00 | -- | 17.48 | -- | -- | -1.51 | -1.51 | -1.35 | 0.6008 | -0.7563 | -- | -- | -7,107,500.00 | -84.49 | -24.61 | -111.31 | -26.01 | -- | -- | -- | -- | -- | -32.26 | 0.4439 | -- | -123.97 | -- | -42.62 | -- | -- | -- |
| Alzinova AB | 309.05k | -18.67m | 350.89m | 5.00 | -- | 2.02 | -- | 1,135.37 | -0.332 | -0.332 | 0.0055 | 1.89 | 0.0025 | -- | 0.4752 | 60,000.00 | -15.15 | -10.77 | -15.91 | -11.27 | -2,621.00 | -- | -6,039.67 | -18,447.90 | -- | -392.89 | 0.0076 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| Herantis Pharma Oyj | 0.00 | -7.16m | 352.62m | 10.00 | -- | 14.77 | 14.53 | -- | -0.0146 | -0.0146 | 0.00 | 0.1012 | 0.00 | -- | -- | 0.00 | -13.93 | -80.46 | -27.32 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0145 | -- | -- | -- | 103.00 | -- | -- | -- |
| Medivir AB | 7.04m | -109.12m | 379.01m | 10.00 | -- | 2.09 | -- | 53.84 | -1.45 | -1.45 | 0.0824 | 1.57 | 0.0311 | -- | 1.12 | 683,300.00 | -48.26 | -28.91 | -61.14 | -34.77 | -1,152.23 | -467.42 | -1,550.15 | -675.96 | -- | -- | 0.0543 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
| Lytix Biopharma AS | -100.00bn | -100.00bn | 390.93m | 10.00 | -- | 6.60 | -- | -- | -- | -- | -- | 1.19 | -- | -- | -- | -- | -- | -56.91 | -- | -65.83 | -- | -- | -- | -771.78 | -- | -- | 0.0482 | -- | -63.82 | 63.94 | -56.77 | -- | -- | -- |
| Initiator Pharma A/S | 0.00 | -26.50m | 398.19m | 3.00 | -- | 14.24 | -- | -- | -0.4688 | -0.4688 | 0.00 | 0.513 | 0.00 | -- | -- | 0.00 | -65.39 | -68.27 | -73.28 | -74.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 27.95 | -- | -- | -- |
| Bergenbio ASA | 521.00k | -155.41m | 404.55m | 15.00 | -- | 2.31 | -- | 776.49 | -5.37 | -5.37 | 0.018 | 4.48 | 0.0023 | -- | 0.0411 | 20,840.00 | -67.73 | -66.15 | -85.55 | -78.74 | -- | -- | -29,828.21 | -11,419.44 | -- | -- | 0.00 | -- | -9.00 | -31.43 | 36.98 | -- | -- | -- |
| SynAct Pharma AB | 0.00 | -170.96m | 421.17m | 5.00 | -- | 2.19 | -- | -- | -4.75 | -4.75 | 0.00 | 4.53 | 0.00 | -- | -- | 0.00 | -61.52 | -125.17 | -67.60 | -151.70 | -- | -- | -- | -- | -- | -231.85 | 0.0076 | -- | -- | -- | -117.54 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Lifecare ASA's reporting currency: Norwegian Krone NOK
5.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management AB (Norway)as of 12 Feb 2024 | 10.36m | 5.30% |
Data from 31 Jul 2024 - 31 Jul 2024Source: FactSet Research Systems Inc.
